ALKEM LABORATORIES Fact Sheet, ALKEM LABORATORIES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Fact Sheet    (ALKE)


Latest: Richa Agarwal's Top 3 Stocks for 2022 Revealed


Here is the latest financial fact sheet of ALKEM LABORATORIES. For more details, see the ALKEM LABORATORIES quarterly results and ALKEM LABORATORIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALKEM LABORATORIES Price History

Price Rs 2,893.1
Mkt Cap Rs m 345,914
Vol '000 1.5
P/E X 19.0
P/CF X 18.3
EPS (TTM) Rs 152.3
1 Day % -0.3
No. of shares m 119.57
1 Week % -6.3
1 Month % -15.3
1 Year % -3.4
52 week H/L Rs 4,067.7/2,835.0
As on May 17, 2022 01:34:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALKEM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ALKEM LABORATORIES EQUITY SHARE DATA
High Rs2,2292,4682,2652,7203,150 
Low Rs1,1751,5781,6931,6602,224 
Sales per share (Unadj.) Rs461.9533.8615.3697.9741.4 
Earnings per share (Unadj.) Rs75.753.464.796.1135.3 
Diluted earnings per shareRs75.753.464.796.1135.3 
Cash flow per share (Unadj.) Rs84.165.480.9117.3158.3 
Dividends per share (Unadj.) Rs15.0013.0016.0025.0030.00 
Adj. dividends per shareRs15.0013.0016.0025.0030.00 
Avg Dividend yield %0.90.60.81.11.1 
Book value per share (Unadj.) Rs373.6406.7454.8515.1616.8 
Adj. book value per shareRs373.6406.7454.8515.1616.9 
Shares outstanding (eoy) m119.57119.57119.57119.57119.57 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x3.73.83.23.13.6 
Avg P/E ratio x22.537.930.622.819.9 
P/CF ratio (eoy) x20.231.024.518.717.0 
Price / Book Value ratio x4.65.04.44.34.4 
Dividend payout %19.824.324.726.022.2 
Avg Mkt Cap Rs m203,473241,880236,619261,868321,244 
No. of employees `000NANANANANA 
Total wages/salary Rs m10,03911,91613,62515,05516,210 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ALKEM LABORATORIES INCOME DATA
Net Sales Rs m55,22663,82573,57283,44488,650 
Other income Rs m1,1201,1548771,0422,332 
Total revenues Rs m56,34664,97974,44984,48690,982 
Gross profit Rs m9,99010,08911,14814,73419,424 
Depreciation Rs m1,0121,4301,9322,5282,746 
Interest Rs m452553546651589 
Profit before tax Rs m9,6469,2609,54712,59818,421 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6002,8761,8101,1052,243 
Profit after tax Rs m9,0476,3847,73611,49316,178 
Gross profit margin %18.115.815.217.721.9 
Effective tax rate %6.231.119.08.812.2 
Net profit margin %16.410.010.513.818.2 
ALKEM LABORATORIES BALANCE SHEET DATA
Current assets Rs m29,17140,13242,16155,05769,288 
Current liabilities Rs m16,89723,83322,17532,44636,041 
Net working cap to sales %22.225.527.227.137.5 
Current ratio x1.71.71.91.71.9 
Inventory Days Days7639241820 
Debtors Days Days4762627266 
Net fixed assets Rs m29,54629,96832,84435,07334,825 
Share capital Rs m239239239239239 
"Free" reserves Rs m44,43348,38954,13961,35473,517 
Net worth Rs m44,67348,62854,37861,59373,756 
Long term debt Rs m1,8161,3072,313739343 
Total assets Rs m58,71870,10075,00690,130104,114 
Interest coverage x22.417.718.520.432.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.91.00.90.9 
Return on assets %16.29.911.013.516.1 
Return on equity %20.313.114.218.721.9 
Return on capital %21.719.717.821.325.7 
Exports to sales %15.217.616.619.222.1 
Imports to sales %00000 
Exports (fob) Rs m8,41011,25912,23816,06119,555 
Imports (cif) Rs m00000 
Fx inflow Rs m8,41011,25912,23816,06119,555 
Fx outflow Rs m1,9032,1032,1052,4832,467 
Net fx Rs m6,5079,15610,13313,57817,088 
ALKEM LABORATORIES CASH FLOW
From Operations Rs m 4,711 2,660 7,797 5,851 12,649 
From Investments Rs m -2,859 -3,572 -3,164 -7,414 -9,985 
From Financial Activity Rs m -1,379 846 -3,789 792 -2,718 
Net Cashflow Rs m 396 1 823 -731 -17 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 57.1%
Institution 19.6%
Non-Institution 23.3%
Total 100.0%
Free Float 42.9%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai - 400013
E-mail investors@alkem.com/contact@alkem.com Web www.alkemlabs.com
Tel 022 3982 9999 Fax 022 2495 2955
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
CHM: Basudeo N Singh COMP SEC: Manish Narang YEAR OF INC: 1973 BSE CODE: 539523 FV (Rs): 2 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare ALKEM LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

Sensex Zooms 1,000 Points; ONGC, Coal India & ITC Surge(01:30 pm)

Share markets in India have extended early gains and are presently trading on a strong note.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - PARMAX PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS